metformin vs glp 1 for pcos use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges - Saadati - 2025 - Diabetes, Obesity and Metabolism Ozempic for PCOS: Weight Loss,

To fine-tune these treatments, specific tests like fasting glucose (levels of 100 mg/dL suggest impaired fasting glucose), oral glucose tolerance tests, and HOMA-IR measurements are used

According to their findings, 53.6% discontinued GLP-1 treatment by the end of year one, with higher rates of discontinuation (64.8%) seen among those using the drugs solely for weight loss, when compared with the 46.5% of those who quit after using the medications as a diabetes treatment

Analysis of 25 OTC GLP-1 patch products: 0 contained semaglutide/tirzepatide, 16% listed no active ingredient

After discontinuation, most patients regain a significant portion of the weight, reversing their initial progress

Increasing Rates of Obesity and Related Metabolic Disorders Various countries are reporting the growth for the obesity treatment market